Day: February 14, 2024

Gabelli Healthcare & WellnessRx Trust Declares First Quarter Distribution of $0.15 Per Share

Written by Customer Service on February 14, 2024. Posted in Dividend Reports And Estimates.

RYE, N.Y., Feb. 14, 2024 (GLOBE NEWSWIRE) — The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.15 per share cash distribution payable on March 21, 2024 to common shareholders of record on March 14, 2024. The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Internal Revenue Code for regulated investment companies, the Fund may pay an adjusting distribution in December which includes any additional income and net realized capital gains in excess of the quarterly distributions for that year. Each quarter, the Board of Trustees reviews the amount of any potential distribution and the income, realized capital...

Gabelli Equity Trust 10% Distribution Policy Reaffirmed And Declared First Quarter Distribution Of $0.15 Per Share

Written by Customer Service on February 14, 2024. Posted in Dividend Reports And Estimates.

RYE, N.Y., Feb. 14, 2024 (GLOBE NEWSWIRE) — The Board of Directors of The Gabelli Equity Trust Inc. (NYSE:GAB) (the “Fund”) reaffirmed and satisfied its 10% distribution policy by declaring a $0.15 per share cash distribution payable on March 21, 2024 to common stock shareholders of record on March 14, 2024. The Fund intends to pay a minimum annual distribution of 10% of the average net asset value of the Fund within a calendar year or an amount sufficient to satisfy the minimum distribution requirements of the Internal Revenue Code for regulated investment companies. The average net asset value of the Fund is based on the average net asset values as of the last day of the four preceding calendar quarters during the year. The net asset value per share fluctuates daily. Each quarter, the Board of Directors reviews the amount of...

Global Wi-Fi As A Service Market to Reach Value of USD 23.07 Billion by 2030 | Skyquest Technology

Written by Customer Service on February 14, 2024. Posted in Mergers And Acquisitions.

Global Wi-Fi as a service market is segmented based on type, and verticals. In terms of type, the market can be segmented into managed service and professional service. Based on verticals, the market is segmented into retail, healthcare, and education- Industry forecast 2023-2030 Westford,USA, Feb. 14, 2024 (GLOBE NEWSWIRE) — According to SkyQuest report, the adoption of global Wi-Fi as a service market is experiencing a notable upswing, primarily driven by its affordability and scalability, rendering it an enticing choice for businesses of all sizes. The increasing need for extensive and high-speed network coverage in today’s data-driven world has spurred a surge in WaaS deployment. Browse in-depth TOC on the “Wi-Fi As A Service Market” Pages – 157 Tables – 61 Figures – 75The growing...

Blüm Holdings Announces Highlights of Proposed Acquisition, Unveils New Brand: Turkey Bag Heroes

Written by Customer Service on February 14, 2024. Posted in Mergers And Acquisitions.

Blum 1Blum 1Blum 2Blum 2Blum 3Blum 3Blum 4Blum 4Blum 5Blum 5Blum 6Blum 6Blum 7Blum 7SANTA ANA, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm Holdings,” “we” or “us”), is pleased to share certain highlights of recently announced proposed acquisition and rollup transaction of three Sacramento retail dispensaries (the “Proposed Acquisition”). Additionally, the Company is excited to introduce a new brand, Turkey Bag Heroes, as part of the strategic rollup efforts in the retail market. If completed, the Proposed Acquisition will mark Blüm Holdings’ entrance into the Sacramento cannabis market. The Sacramento retail cannabis market exhibits both maturity and opportunity. With a growing regular consumer base, we believe the...

Ashvattha Therapeutics to Participate in Upcoming Investor Conferences

Written by Customer Service on February 14, 2024. Posted in Earnings Releases And Operating Results.

REDWOOD CITY, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target activated cells in regions of inflammation, today announced that members of its senior management team will participate in two upcoming investor conferences. Conference Details: BIO CEO & Investor Conference Format: Corporate PresentationDate: Tuesday, February 27, 2024Time: 11:45 – Noon ETLocation: The New York Marriott Marquis Ashvattha’s Co-Founder and Chief Executive Officer, Jeffrey Cleland, Ph.D., and Chief Financial Officer, Paul Cayer, will be available for one-on-one meetings. If you are interested in a meeting, please reach out via the BIO One-on-One Partnering system. Evercore ISI 2024 Emerging...

SEALSQ Partners with CarbonMinus to Revolutionize the IoT Industry through Sustainable Practices and Blockchain Technology

Written by Customer Service on February 14, 2024. Posted in Public Companies.

Tortola, British Virgin Islands , Feb. 14, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (“SEALSQ” or “Company”) (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced a strategic partnership with CarbonMinus, leveraging the innovative SEALCOIN as a means to offset CO2 emissions and drive the decarbonization of the IoT industry. This collaboration marks a significant milestone at the intersection of energy management and sustainability, enabling businesses to not only redefine success but also to embrace a future where environmental stewardship and profitability go hand in hand. Strategic Empowerment through Energy and Resource Dynamics SEALSQ is committed to equipping businesses with the tools and knowledge needed...

SweetWater 420 Fest Announces 2024 Lineup With Headliners Beck and Slightly Stoopid

Written by Customer Service on February 14, 2024. Posted in Public Companies.

Two-Day Festival Will Feature Performances from 25 Musicians, April 20 & 21, at Atlanta’s Historic Pullman YardsSweetWater 420 FestSweetWater 420 FestATLANTA, Feb. 14, 2024 (GLOBE NEWSWIRE) — SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in the Southeast and a subsidiary of Tilray Brands, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY and TSX: TLRY), today announced the lineup for this year’s SweetWater 420 Fest, one of Atlanta’s most anticipated music festivals, which Beck and Slightly Stoopid will headline. Presented by SweetWater Brewing and Pullman Yards, the festival will be hosted at Atlanta’s Pullman Yards on April 20-21. This year’s festival will also feature performances by Big Gigantic, Black Pumas, Gov’t Mule, Trombone Shorty, Cory Wong, Grace Potter,...

Apollo to Present at the Bank of America Securities 2024 Financial Services Conference

Written by Customer Service on February 14, 2024. Posted in Public Companies.

NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Martin Kelly, Chief Financial Officer, will participate in a fireside chat at the Bank of America Securities Financial Services Conference on Thursday, February 22, 2024 at 9:40 am ET. A live webcast of the event will be available on Apollo’s Investor Relations website at ir.apollo.com. For those unable to join live, a replay will be available shortly after the event. About Apollo Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade to private equity with a focus on three investing strategies: yield, hybrid, and equity. For more than three decades, our investing expertise across our fully integrated...

AIM ImmunoTech Announces First Subject Dosed in the Netherlands for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi (durvalumab) for the Treatment of Pancreatic Cancer

Written by Customer Service on February 14, 2024. Posted in Public Companies.

Phase 1b portion of the study expected to be completed within six monthsErasmus Medical CenterErasmus Medical CenterOCALA, Fla., Feb. 14, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the first subject has been dosed at Erasmus Medical Center (“Erasmus MC”) in a Phase 1b/2 clinical trial combining AIM’s Ampligen® (rintatolimod) with AstraZeneca’s anti-PD-L1 immune checkpoint inhibitor Imfinzi® (durvalumab) for the treatment of late-stage pancreatic cancer (the “DURIPANC Study”). The DURIPANC Study is an investigator-initiated, exploratory, open-label, single-center study with the full name “Combining anti-PD-L1 immune checkpoint inhibitor durvalumab with TLR-3 agonist rintatolimod in patients with metastatic pancreatic ductal adenocarcinoma for therapy efficacy.”...

SFWJ DBA MedCana Announces a Major Multiyear Contract between Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana and Danziger Colombia

Written by Customer Service on February 14, 2024. Posted in Public Companies.

AUSTIN, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) — – via IBN – SFWJ DBA MedCana announces that Eko2o S.A.S, a Majority Controlled subsidiary of MedCana/SWJ in Colombia and a leading provider of greenhouse infrastructure and agricultural technology, proudly announces a significant partnership with Danziger Colombia. This strategic agreement, expected to generate between $2.5 million and $3 million in revenue over the next three years, marks a pivotal moment for both organizations in their commitment to innovative agricultural practices. Eko2o will be providing greenhouse infrastructure services, irrigation products and technology as well as other technologies related to Danziger’s flower operations in Colombia. Juan Ricardo Velez, CEO of Eko2o S.A.S., expressed enthusiasm about the collaboration, stating: “We are thrilled to...

Day: February 14, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals